Lake Street Capital Lowers Cardiovascular Systems to Sell
CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Under 56% of Cardiovascular Systems' investor base is looking to short. The analysis of current outlook of investing in Cardiovascular Systems suggests that many traders are alarmed regarding Cardiovascular Systems' prospects. Cardiovascular Systems' investing sentiment shows overall attitude of investors towards Cardiovascular Systems.
Cardiovascular |
Lake Street Capital lowered shares of Cardiovascular Systems from a buy rating to a sell rating in a research report sent to investors on Thursday, The Fly reports. Other analysts have also issued reports about the stock. StockNews.com began coverage on shares of Cardiovascular Systems in a research report on Wednesday,
Read at thelincolnianonline.com
Cardiovascular Systems Fundamental Analysis
We analyze Cardiovascular Systems' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardiovascular Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardiovascular Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Cardiovascular Systems is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Cardiovascular Systems Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardiovascular Systems stock to make a market-neutral strategy. Peer analysis of Cardiovascular Systems could also be used in its relative valuation, which is a method of valuing Cardiovascular Systems by comparing valuation metrics with similar companies.
Peers
Cardiovascular Systems Related Equities
NPCE | Neuropace | 5.11 | ||||
FNA | Paragon 28 | 5.00 | ||||
SIBN | Si Bone | 4.49 | ||||
NARI | Inari Medical | 3.11 | ||||
KIDS | Orthopediatrics Corp | 2.36 | ||||
OFIX | Orthofix Medical | 1.48 | ||||
ITGR | Integer Holdings | 0.96 | ||||
MXCT | MaxCyte | 0.48 | ||||
LIVN | LivaNova PLC | 0.12 | ||||
CNMD | CONMED | 0.07 | ||||
ESTA | Establishment Labs | 0.02 | ||||
NVRO | Nevro Corp | 0.23 | ||||
TMCI | Treace Medical | 0.25 | ||||
CVRX | CVRx | 0.29 | ||||
RPID | Rapid Micro | 0.95 | ||||
GKOS | Glaukos Corp | 1.67 | ||||
SGHT | Sight Sciences | 2.01 | ||||
OM | Outset Medical | 2.27 | ||||
BRKR | Bruker | 2.39 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |